Company Filing History:
Years Active: 2015
Title: Claude Leclerc: Innovator in Immunostimulatory Agents
Introduction
Claude Leclerc is a notable inventor based in Navarra, Spain. He has made significant contributions to the field of biomedicine, particularly in the development of immunostimulatory agents. His work focuses on utilizing specific polypeptides to enhance immune responses.
Latest Patents
Claude Leclerc holds a patent for "Agents and methods based on the use of the EDA domain of fibronectin." This invention pertains to the use of a polypeptide that includes a sequence corresponding to the EDA domain of fibronectin. The polypeptide can bind to TLR4, which is crucial for immune system activation. The patent also covers production methods and applications of this immunostimulatory agent.
Career Highlights
Leclerc is associated with Proyecto De Biomedicina Cima, S.L., where he continues to advance his research. His innovative approach has the potential to impact therapeutic strategies in immunology.
Collaborations
He collaborates with esteemed colleagues such as Juan Jose Lasarte Sagastibelza and Marta Gorraiz Ayala, contributing to a dynamic research environment.
Conclusion
Claude Leclerc's work exemplifies the intersection of innovation and biomedicine, showcasing the importance of his contributions to immunostimulatory agents. His patent reflects a significant advancement in the field, promising new avenues for therapeutic development.